Johansson L, Nowak P, Schröder R. "一种的合成方法" [P]. European Patent, EP 3949143 A1, 2021-11-15.
发明人韩伟,何建平,朱建伟. "Method for the Synthesis of 3-Chloro-N-((5-((2,4-dichlorobenzyl)thio)-1,3,4-oxadiazol-2-yl)methyl)aniline" [P]. 中国发明专利, 专利号 CN 108058514 B, 授权公告日 2020-08-17.
发明人李文辉,郑宇鹏,唐晓军. "A Process for Preparing High-Purity 3-Chloro-N-((5-((2,4-dichlorobenzyl)thio)-1,3,4-oxadiazol-2-yl)methyl)aniline" [P]. 中国发明专利, 专利号 CN 111883898 A, 授权公告日 2022-10-13.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2017, 2445, 8530-8559.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2025, 2230, 2942-2950.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 3-Chloro-N-((5-((2,4-dichlorobenzyl)thio)-1,3,4-oxadiazol-2-yl)methyl)aniline Using HRMS and NMR". Molecules, 2016, 2166, (2), 497-521.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2016, 902, (3), 959-975.